GO:0030621 U4 snRNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030621 (U4 snRNA binding) is a molecular_function term describing the selective binding of a protein or ribonucleoprotein to U4 small nuclear RNA (U4 snRNA).
• U4 snRNA is a core component of the major spliceosome, where it base-pairs with U6 snRNA and is remodeled during spliceosome activation.
• Key U4 snRNA-binding proteins include hPrp31, which recognizes the 5' stem-loop of U4 and U4atac snRNAs, and Sm/LSm proteins that assemble on the Sm site.
• The NHPX/15.5-kD protein binds a specific site in U4 snRNA and is required for its nucleolar localization, independently of Sm proteins or U6 association.
• Dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa, and biallelic variants in RNU4-2 cause a recessive neurodevelopmental syndrome.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of U4 snRNA-binding factors in splicing and disease.
Description
GO:0030621, U4 snRNA binding, is a Gene Ontology molecular_function term defined as binding to a U4 small nuclear RNA (U4 snRNA). U4 snRNA is an essential small nuclear RNA that functions within the major spliceosome, the ribonucleoprotein machine that catalyzes pre-mRNA splicing. Proteins that specifically recognize U4 snRNA are required for spliceosome assembly, catalytic activation, and recycling, making this binding activity central to eukaryotic gene expression. Researchers study U4 snRNA binding to understand how spliceosomal small nuclear ribonucleoproteins (snRNPs) are built, how RNA-RNA rearrangements are controlled, and how mutations in U4 snRNA or its binding partners contribute to human disease. The term is also relevant to non-canonical roles of U4 snRNA, including its nucleolar localization and assembly with the NHPX/15.5-kD protein. Because U4 snRNA binding is a molecular recognition event rather than a catalytic activity, it is typically assayed through RNA-binding experiments, structural biology, and genetic perturbation of the responsible proteins.
U4 snRNA binding At A Glance
| GO ID | GO:0030621 |
|---|---|
| GO term | U4 snRNA binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Selective binding to U4 small nuclear RNA, enabling spliceosomal snRNP assembly and U4/U6 rearrangement |
| Representative binders | hPrp31, Sm/LSm proteins, NHPX/15.5-kD protein |
| Associated process | Pre-mRNA splicing via the major spliceosome |
| Disease relevance | Retinitis pigmentosa and neurodevelopmental syndromes linked to U4/U6 snRNA variants |
What Is GO:0030621?
U4 snRNA binding (GO:0030621) describes the selective, non-covalent interaction of a protein or protein complex with U4 small nuclear RNA. This activity is distinct from general RNA binding because it requires recognition of sequence or structural features unique to U4 snRNA, such as its 5' stem-loop or Sm site. In the spliceosome, U4 snRNA binding proteins mediate the incorporation of U4 into the U4/U6 snRNP and later release U4 during catalytic activation. The term is a molecular_function annotation and does not by itself imply a downstream process, although U4 snRNA binding is most commonly observed in pre-mRNA splicing and snRNP assembly.
Why Is U4 snRNA binding Important in Cell Biology?
U4 snRNA binding is important because it controls the assembly and activation of the major spliceosome, the machinery responsible for removing introns from most human pre-mRNAs. Without proper U4 snRNA recognition, U4/U6 snRNP formation and the subsequent U4 release step fail, blocking spliceosome activation and altering gene expression. This activity also connects to human disease: dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa, and biallelic variants in RNU4-2 cause a recessive neurodevelopmental syndrome. In addition, U4 snRNA binding proteins such as hPrp31 are linked to spliceosomal regulation and are studied as potential targets for understanding splicing fidelity. The term therefore bridges basic RNA biology, structural recognition, and clinical genetics.
• Required for assembly of the U4/U6 snRNP, a building block of the major spliceosome.
• Enables the U4/U6 RNA-RNA rearrangement that precedes catalytic activation of the spliceosome.
• hPrp31 specifically recognizes the 5' stem-loop of U4 and U4atac snRNAs, providing a structural basis for dual specificity.
• Sm proteins assemble on the U4 snRNA Sm site, and this assembly is a prerequisite for snRNP function.
• The NHPX/15.5-kD protein binds U4 snRNA at a site required for nucleolar localization, revealing a non-splicing role.
• Suppressors of U4 snRNA mutations identified a novel U6 snRNP protein with RNA-binding motifs, linking U4 function to U6 snRNP composition.
• Dominant U4 and U6 snRNA variants cause retinitis pigmentosa, highlighting the clinical importance of U4 snRNA recognition.
• Biallelic RNU4-2 variants cause a recessive neurodevelopmental syndrome with white matter changes.
• U4 snRNA-binding factors are candidate targets for CRISPR-based functional genomics of splicing.
• Understanding U4 snRNA binding informs RNA-targeted therapeutic strategies for spliceosome-related diseases.
Molecular Mechanism of U4 snRNA binding
Recognition of the U4 snRNA 5' stem-loop by hPrp31
In simple terms: A protein called hPrp31 grabs a specific hairpin shape in U4 snRNA.
hPrp31 binds the 5' stem-loop of U4 snRNA and also recognizes U4atac snRNA, providing the structural basis for dual U4 and U4atac specificity. This interaction is a key molecular recognition event that helps incorporate U4 into the spliceosomal snRNP network.
Sm site recognition and Sm/LSm assembly
In simple terms: A ring of Sm proteins clamps onto a short U4 snRNA sequence.
The Sm binding site of human U4 snRNA has been characterized structurally, and molecular dynamics simulations have described its conformation. Sm proteins assemble on this site, and this assembly is a prerequisite for U4 snRNP function. The Sm site is therefore a distinct U4 snRNA-binding determinant separate from the 5' stem-loop.
NHPX/15.5-kD protein binding and nucleolar localization
In simple terms: Another protein, NHPX/15.5-kD, binds U4 snRNA and helps it go to the nucleolus.
U4 snRNA nucleolar localization requires the NHPX/15.5-kD protein binding site but does not require Sm proteins or U6 snRNA association. This finding shows that U4 snRNA binding can serve functions beyond splicing, including subcellular localization.
U4/U6 rearrangement and spliceosome activation
In simple terms: U4 and U6 RNAs swap partners so the spliceosome can cut RNA.
During spliceosome activation, U4 snRNA is released from U6 snRNA, a rearrangement that depends on proper U4 snRNA recognition and snRNP remodeling. Suppressors of a U4 snRNA mutation defined a novel U6 snRNP protein with RNA-binding motifs, linking U4 function to U6 snRNP composition. This step is essential for catalytic activation of the spliceosome.
Regulation by RNA-binding motifs and protein cofactors
In simple terms: Helper proteins and RNA-binding motifs control how tightly U4 snRNA is held.
U4 snRNA-binding proteins contain RNA-binding motifs, and genetic suppressors of U4 snRNA mutations identified a novel U6 snRNP protein with such motifs. hPrp31 provides a structural example of how a protein can discriminate between U4 and U4atac snRNAs. These features indicate that U4 snRNA binding is regulated at the level of protein-RNA complementarity and cofactor assembly.
Key Genes Involved in GO:0030621 U4 snRNA binding
The following genes and proteins are experimentally linked to U4 snRNA binding or to the U4 snRNP context in which this activity occurs.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRPF31 | Encodes hPrp31, which binds the 5' stem-loop of U4 and U4atac snRNAs | Structural and mutational studies of U4 snRNA recognition |
| RNU4-1 | U4 snRNA gene; dominant variants cause retinitis pigmentosa | Disease modeling of U4 snRNA variants |
| RNU4-2 | U4 snRNA gene; biallelic variants cause a recessive neurodevelopmental syndrome | Noncoding RNA disease genetics |
| RNU6-1 | U6 snRNA gene; dominant variants cause retinitis pigmentosa | Comparative U4/U6 snRNA disease studies |
| SNRPB | Sm protein component that assembles on the U4 snRNA Sm site | Sm site recognition and snRNP assembly |
| SNRPD1 | Sm protein component of the U4 snRNP | Sm core assembly assays |
| SNRPD2 | Sm protein component of the U4 snRNP | Sm core assembly assays |
| SNRPD3 | Sm protein component of the U4 snRNP | Sm core assembly assays |
| SNRPE | Sm protein component of the U4 snRNP | Sm core assembly assays |
| SNRPF | Sm protein component of the U4 snRNP | Sm core assembly assays |
| SNRPG | Sm protein component of the U4 snRNP | Sm core assembly assays |
| NHP2 | Encodes NHPX/15.5-kD protein that binds U4 snRNA for nucleolar localization | Nucleolar localization and non-splicing U4 functions |
| PRPF8 | Spliceosomal protein involved in activation after U4 release | Spliceosome activation studies |
| PRPF6 | U4/U6 snRNP-associated protein in the spliceosome | snRNP assembly and splicing assays |
| EFTUD2 | Spliceosomal GTPase involved in U4/U6 rearrangement | Catalytic activation and U4 release |
| DDX23 | RNA helicase implicated in spliceosome remodeling | U4/U6 unwinding studies |
| LSM2 | LSm protein related to U6 snRNP function | U4/U6 snRNP composition |
How Is U4 snRNA binding Regulated?
U4 snRNA binding is regulated by the availability of its protein partners and by the conformational state of the snRNP. hPrp31 binding to the U4 5' stem-loop provides specificity, while Sm protein assembly on the Sm site is a separate and required step. The NHPX/15.5-kD protein binding site controls nucleolar localization of U4 snRNA independently of Sm proteins and U6 association. Genetic suppressors of a U4 snRNA mutation identified a novel U6 snRNP protein with RNA-binding motifs, indicating that U4 function is modulated by additional RNA-binding factors. At the level of the spliceosome, U4 release and U4/U6 rearrangement are coupled to activation and are regulated by spliceosomal ATPases and helicases.
U4 snRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNU4-1 | Retinitis pigmentosa | Knock-in of patient U4 snRNA variants in retinal organoids |
| RNU4-2 | Recessive neurodevelopmental syndrome with white matter changes | Knockout and knock-in in neural progenitor cells |
| RNU6-1 | Retinitis pigmentosa | Comparative U4/U6 snRNA variant models |
| PRPF31 | U4 snRNA recognition and splicing | Point-mutation knock-in of hPrp31 RNA-binding residues |
| NHP2 | U4 snRNA nucleolar localization | Knockout and tagged knock-in for localization studies |
Retinitis pigmentosa caused by U4 and U6 snRNA variants
De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa. These findings directly link U4 snRNA sequence integrity, and by extension U4 snRNA binding, to retinal degeneration. The discovery of U4 snRNA variants as a cause of retinitis pigmentosa expanded the list of noncoding RNA genes implicated in Mendelian disease.
Recessive neurodevelopmental syndrome from RNU4-2 variants
Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes. This establishes U4 snRNA as a dosage-sensitive gene in neurodevelopment and suggests that U4 snRNA-binding factors may modify the phenotype.
Spliceosome dysfunction and disease
Because U4 snRNA binding is required for spliceosome activation, defects in this activity can impair pre-mRNA splicing broadly. Mutations in spliceosomal proteins and snRNA genes are increasingly recognized in human disease, including retinal and neurological disorders. Studying U4 snRNA recognition therefore provides a mechanistic entry point for understanding spliceosome-related pathology.
From U4 snRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for U4 snRNA binding? | CRISPR knockout followed by RNA immunoprecipitation |
| Does a specific residue mediate U4 snRNA recognition? | Point-mutation knock-in of the RNA-binding domain |
| Does a disease variant alter U4 snRNP assembly? | Knock-in of patient U4 snRNA or protein variants |
| Where does the U4 snRNA-binding protein localize? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a U4 snRNA-binding factor alter splicing? | Overexpression cell models with RNA-seq readout |
| Which cofactors cooperate with U4 snRNA binding? | Knockout of candidate cofactors and proteomics |
How to Study the U4 snRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation | Physical association of protein with U4 snRNA | Validation of candidate U4 snRNA-binding proteins |
| UV crosslinking | Direct RNA-protein contacts | Mapping U4 snRNA binding sites |
| In vitro splicing | Spliceosome activity dependent on U4 | Functional testing of U4 snRNA variants |
| snRNP assembly assay | Formation of U4 snRNP complexes | Sm core and hPrp31 assembly studies |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of U4 snRNA-binding factors |
| Point-mutation knock-in | Effect of specific residues | Dissecting RNA-binding interfaces |
| RNA-seq | Global splicing changes | Measuring consequences of U4 snRNA binding defects |
| Proteomics | Protein composition of U4 snRNP | Identifying cofactors and assembly intermediates |
RNA immunoprecipitation and UV crosslinking
RNA immunoprecipitation (RIP) and UV crosslinking followed by immunoprecipitation can detect direct binding of proteins to U4 snRNA. These methods are used to test whether a candidate protein associates with U4 snRNA in cells and to map binding sites.
Structural biology of U4 snRNA-protein complexes
Structural studies have revealed how hPrp31 recognizes the U4 and U4atac snRNA 5' stem-loop. Molecular dynamics simulations have also been used to model the Sm binding site of human U4 snRNA. These approaches define the chemical basis of U4 snRNA binding.
Splicing and snRNP assembly assays
In vitro splicing assays and snRNP assembly assays measure the functional consequences of U4 snRNA binding defects. Suppressor screens of U4 snRNA mutations identified a novel U6 snRNP protein, illustrating the power of genetic assays.
CRISPR screens and functional genomics
CRISPR knockout and interference screens can identify genes required for U4 snRNP function and splicing. These screens are complemented by RNA-seq to measure splicing changes after perturbation.
How CRISPR Can Be Used to Study GO:0030621 U4 snRNA binding
Knockout
CRISPR knockout of genes encoding U4 snRNA-binding proteins, such as PRPF31 or Sm core components, can test whether they are required for U4 snRNP assembly and splicing. Knockout of NHP2 can test the requirement for the NHPX/15.5-kD protein binding site in U4 snRNA nucleolar localization.
Point Mutation
Point-mutation knock-in can be used to alter specific residues in the U4 snRNA-binding interface of hPrp31 or Sm proteins, allowing precise structure-function analysis. This approach is also suitable for modeling disease-associated variants in U4 snRNA genes.
Knock-in
Knock-in of patient-derived U4 or U6 snRNA variants, or of RNU4-2 variants, enables disease modeling in relevant cell types. Tagged knock-in of U4 snRNA-binding proteins supports localization and interaction studies.
Overexpression
Overexpression of U4 snRNA-binding factors can reveal dominant effects on splicing and snRNP composition. Overexpression combined with RNA-seq can identify splicing changes driven by altered U4 snRNA recognition.
How EDITGENE Supports U4 snRNA binding Research
Researchers studying U4 snRNA binding-related genes often need to determine whether a candidate gene is causally involved in U4 snRNP assembly, splicing, or disease. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for U4 snRNA binding research.
Frequently Asked Questions About U4 snRNA binding
What is U4 snRNA binding?
U4 snRNA binding (GO:0030621) is the molecular function of selectively binding to U4 small nuclear RNA, a core component of the major spliceosome.
What genes are involved in U4 snRNA binding?
Genes include PRPF31, which encodes hPrp31, Sm core genes such as SNRPB and SNRPD1-3, and NHP2, which encodes the NHPX/15.5-kD protein.
What is the GO ID for U4 snRNA binding?
The Gene Ontology ID for U4 snRNA binding is GO:0030621, and its ontology aspect is molecular_function.
How does hPrp31 recognize U4 snRNA?
hPrp31 binds the 5' stem-loop of U4 snRNA and also recognizes U4atac snRNA, providing a structural basis for dual specificity.
What is the role of the Sm site in U4 snRNA?
The Sm site is a U4 snRNA sequence where Sm proteins assemble, and this assembly is required for U4 snRNP function.
Does U4 snRNA have functions outside splicing?
Yes, U4 snRNA nucleolar localization requires the NHPX/15.5-kD protein binding site but not Sm proteins or U6 snRNA association.
What diseases are linked to U4 snRNA variants?
Dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa, and biallelic RNU4-2 variants cause a recessive neurodevelopmental syndrome.
How can I study U4 snRNA binding in the lab?
Common methods include RNA immunoprecipitation, UV crosslinking, in vitro splicing, snRNP assembly assays, and CRISPR perturbation.
What CRISPR models are useful for U4 snRNA binding research?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression models can test requirement, specificity, localization, and dosage effects.
Why is U4 snRNA binding important for splicing?
U4 snRNA binding enables U4/U6 snRNP assembly and the U4 release step required for catalytic activation of the spliceosome.
Conclusion
GO:0030621 U4 snRNA binding defines a selective molecular recognition event that is essential for spliceosome assembly and activation. Proteins such as hPrp31, Sm core components, and NHPX/15.5-kD mediate distinct aspects of U4 snRNA recognition, and their dysfunction is linked to retinitis pigmentosa and neurodevelopmental disease. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide a direct route to test causality and mechanism in this pathway. As noncoding RNA variants continue to be discovered in human disease, U4 snRNA binding will remain a focal point for both basic splicing research and therapeutic development.
References
- 1. Wilkinson ME et al.. 2020. RNA Splicing by the Spliceosome.. Annu Rev Biochem 89:359-388 PMID: 31794245
- 2. Quinodoz M et al.. 2026. De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.. Nat Genet 58(1):169-179 PMID: 41513982
- 3. Quinodoz M et al.. 2025. De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa.. medRxiv PMID: 39830270
- 4. Gerbi SA et al.. 2003. U4 snRNA nucleolar localization requires the NHPX/15.5-kD protein binding site but not Sm protein or U6 snRNA association.. J Cell Biol 162(5):821-32 PMID: 12939253
- 5. Liu S et al.. 2011. Structural basis for the dual U4 and U4atac snRNA-binding specificity of spliceosomal protein hPrp31.. RNA 17(9):1655-63 PMID: 21784869
- 6. Guo J et al.. 2000. Structure of the Sm binding site from human U4 snRNA derived from a 3 ns PME molecular dynamics simulation.. J Biomol Struct Dyn 18(3):335-44 PMID: 11149510
- 7. Shannon KW et al.. 1991. Suppressors of a U4 snRNA mutation define a novel U6 snRNP protein with RNA-binding motifs.. Genes Dev 5(5):773-85 PMID: 1827420
- 8. Rius R et al.. 2026. Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.. Nat Genet 58(4):761-773 PMID: 41951959
